Sponge Cytology-Sampling Device Promising for Barrett Esophagus Dx

Share this content:
Sponge Cytology-Sampling Device Promising for Barrett Esophagus Dx
Sponge Cytology-Sampling Device Promising for Barrett Esophagus Dx

MONDAY, Feb. 4, 2019 (HealthDay News) -- A swallowable cellular retrieval capsule sponge cytology-sampling device, EsophaCap, in combination with a methylation biomarker panel represents a promising strategy for diagnosing Barrett esophagus (BE), according to a study published online Jan. 22 in Clinical Cancer Research.

Zhixiong Wang, from the First Affiliated Hospital of Sun Yat-Sen University in Guangzhou, China, and colleagues conducted a prospective cohort study on 80 patients (52 in the training set and 28 in the test set). Methylation on beads was used to extract and bisulfite-convert DNA. Quantitative methylation-specific polymerase chain reaction was then used to assess methylation levels of eight candidate markers.

The researchers found that five of eight candidate methylation biomarkers were significantly higher in BE patients than controls in the training set. A four biomarker-plus-age lasso regression model was constructed for BE diagnosis and had an area under the receiver operating characteristic curve (AUC) of 0.894, with sensitivity and specificity of 94.4 and 62.2 percent, respectively, in the training set. In an independent test set, the model had high accuracy (AUC, 0.929), with sensitivity and specificity of 78.6 and 92.8 percent, respectively.

"These findings suggest that this approach is a promising low-cost strategy for the early detection of BE," the authors write. "Future large-scale studies are indicated to consolidate and further validate this strategy."

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves First Customizable Insulin Pump

FDA Approves First Customizable Insulin Pump

Product works by delivering insulin under the skin at set or variable rates

Sepsis Common in Terminal Hospitalizations, Discharges

Sepsis Common in Terminal Hospitalizations, Discharges

Most common underlying causes of death in sepsis are solid and hematologic cancers, chronic heart disease

Fewer Older Men Assessed, Treated for Osteoporosis

Fewer Older Men Assessed, Treated for Osteoporosis

Fewer older men than women, even with higher risk, undergo DXA screening, 25(OH)D measurement

is free, fast, and customized just for you!




Already a member?

Sign In Now »